Publications by authors named "Daniel Wynn"

Claim this Profile
R
RAC1 Regulates Shh-Medulloblastoma Growth via GLI-Mediated Transcription.
Nitish Jangde, Mi Hye Lee, Luz Ruiz, Isabelle Egan, Anna M Jermakowicz, Daniel Wynn

bioRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wnt signaling inhibits casein kinase 1α activity by modulating its interaction with protein phosphatase 2A.
Chen Shen, Wenhui Lu, Siva B Merugu, Aradhana Bharti, Said M Afify, Daniel T Wynn

Cell Rep· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvements in no evidence of disease activity with ublituximab vs. teriflunomide in the ULTIMATE phase 3 studies in relapsing multiple sclerosis.
Enrique Alvarez, Lawrence Steinman, Edward J Fox, Hans-Peter Hartung, Peiqing Qian, Daniel Wynn

Front Neurol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the role of casein kinase 1α splice variants across cancer cell lines.
Ricardo A Meléndez, Daniel T Wynn, Siva Bharath Merugu, Prerna Singh, Kenton P Kaplan

Biochem Biophys Res Commun· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triptolide and its prodrug Minnelide target high-risk MYC-amplified medulloblastoma in preclinical models.
Jezabel Rodriguez-Blanco, April D Salvador, Robert K Suter, Marzena Swiderska-Syn, Isabel Palomo-Caturla, Daniel T Wynn

J Clin Invest· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives.
Mark S Freedman, Patricia K Coyle, Kerstin Hellwig, Barry Singer, Daniel Wynn

Neurol Ther· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of switching to teriflunomide in older patients with relapsing multiple sclerosis: A real-world retrospective multicenter analysis.
Regina Berkovich, Donald Negroski, Daniel Wynn, Daniel Sellers, Kristen G Bzdek

Mult Scler Relat Disord· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Druggable UHRF1/DNMT1/GLI Complex Regulates Sonic Hedgehog-Dependent Tumor Growth.
Fan Yang, Jezabel Rodriguez-Blanco, Jun Long, Marzena Swiderska-Syn, Daniel T Wynn

Mol Cancer Res· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiprotein GLI Transcriptional Complexes as Therapeutic Targets in Cancer.
Fan Yang, Daniel T Wynn, Chen Shen, Nagi G Ayad, David J Robbins

Life (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein arginine methyltransferase 5 regulates SHH-subgroup medulloblastoma progression.
Daniel T Wynn, Jezabel Rodriguez-Blanco, Jun Long, Fan Yang, Chen Shen

Neurooncol Adv· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Lawrence Steinman, Edward Fox, Hans-Peter Hartung, Enrique Alvarez, Peiqing Qian, Daniel Wynn

N Engl J Med· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noncanonical activation of GLI signaling in SOX2 cells drives medulloblastoma relapse.
Marzena Swiderska-Syn, Júlia Mir-Pedrol, Alexander Oles, Olga Schleuger, April D Salvador, Daniel T Wynn

Sci Adv· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Results from a multicenter, randomized, double-blind, placebo-controlled study of repository corticotropin injection for multiple sclerosis relapse that did not adequately respond to corticosteroids.
Daniel Wynn, Lawrence Goldstick, William Bauer, Enxu Zhao, Eva Tarau

CNS Neurosci Ther· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The E3 ubiquitin ligase component, Cereblon, is an evolutionarily conserved regulator of Wnt signaling.
Chen Shen, Anmada Nayak, Leif R Neitzel, Amber A Adams, Maya Silver-Isenstadt, Daniel T Wynn

Nat Commun· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monomethyl fumarate has better gastrointestinal tolerability profile compared with dimethyl fumarate.
Daniel Wynn, Thomas W Lategan, Tiffany N Sprague, Franck S Rousseau, Edward J Fox

Mult Scler Relat Disord· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casein Kinase 1α as a Regulator of Wnt-Driven Cancer.
Chen Shen, Anmada Nayak, Ricardo A Melendez, Daniel T Wynn, Joshua Jackson

Int J Mol Sci· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis.
Richard Phelps, Jonathan A Winston, Daniel Wynn, Mario Habek, Hans-Peter Hartung

Mult Scler· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enduring Clinical Value of Copaxone® (Glatiramer Acetate) in Multiple Sclerosis after 20 Years of Use.
Daniel R Wynn

Mult Scler Int· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of bacterial contamination in food matrices by integration of quorum sensing in a paper-strip test.
Daniel Wynn, Nilesh Raut, Smita Joel, Patrizia Pasini, Sapna K Deo

Analyst· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineering Rugged Field Assays to Detect Hazardous Chemicals Using Spore-Based Bacterial Biosensors.
Daniel Wynn, Sapna Deo, Sylvia Daunert

Methods Enzymol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transcriptional regulatory proteins as biosensing tools.
Kendrick Turner, Smita Joel, Jessika Feliciano, Agatha Feltus, Patrizia Pasini, Daniel Wynn

Chem Commun (Camb)· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alemtuzumab improves neurological functional systems in treatment-naive relapsing-remitting multiple sclerosis patients.
Edward J Fox, Daniel Wynn, Alasdair J Coles, Jeffrey Palmer, David H Margolin

J Neurol Sci· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GLACIER: An open-label, randomized, multicenter study to assess the safety and tolerability of glatiramer acetate 40 mg three-times weekly versus 20 mg daily in patients with relapsing-remitting multiple sclerosis.
Jerry S Wolinsky, T Erik Borresen, Dennis W Dietrich, Daniel Wynn, Yulia Sidi

Mult Scler Relat Disord· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of switching directly to oral fingolimod from injectable therapies: Results of the randomized, open-label, multicenter, Evaluate Patient OutComes (EPOC) study in relapsing multiple sclerosis.
Edward Fox, Keith Edwards, Gordon Burch, Daniel R Wynn, Chris LaGanke

Mult Scler Relat Disord· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Mark Cascione, Daniel Wynn, Luigi M Barbato, Linda Pestreich, Lesley Schofield

J Med Econ· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis